Furthermore, Chk1 heterozygosity was shown to synergize with p53 haplo-insufficiency in promoting breast cancer24 and significantly accelerated the onset and tumor incidence in Chk2−/− mice that most frequently developed lymphoma25. This evidence concerns the gene CHEK2 and neoplasm.